Loading clinical trials...
Loading clinical trials...
A Randomized, Double Blind, Placebo-Controlled Phase 3 Study of the Safety and Efficacy of DPI-386 Nasal Gel on Ocean Going Vessels for the Prevention and Treatment of Nausea Associated With Motion Sickness
Conditions
Interventions
Scopolamine Nasal Gel
Placebo
Locations
1
United States
Collaborative Neuroscience Network, LLC
Long Beach, California, United States
Start Date
April 26, 2019
Primary Completion Date
May 19, 2019
Completion Date
June 19, 2019
Last Updated
December 3, 2019
NCT03772340
NCT06056622
NCT04420949
NCT05548270
NCT05628220
NCT04331561
Lead Sponsor
Repurposed Therapeutics, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions